FDA Biologics (BLA & Biosimilars)Original article
Vaccines and Related Biological Products Advisory Committee October 1, 2026 Meeting Announcement - 10/01/2026
AdComInfluenza virus vaccinesNeutral
AI Analysis
Summary
The FDA's Vaccines and Related Biological Products Advisory Committee is scheduled to meet on October 1, 2026 to discuss and recommend influenza virus vaccine strains for the 2027 Southern Hemisphere influenza season.
Outcome Details
Committee to discuss strain selection for influenza virus vaccines for the 2027 Southern Hemisphere influenza season
Importance:3/10
Sentiment:
0.00
influenza vaccinesstrain selectionsouthern hemisphereadvisory committeeFDA
Read the original article
Published by FDA Biologics (BLA & Biosimilars) on October 1, 2026 11:00 AM